Hennessy Advisors Inc. Has $8.33 Million Position in Fresenius Medical Care AG & Co. KGaA $FMS

Hennessy Advisors Inc. reduced its stake in Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) by 6.1% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 349,500 shares of the company’s stock after selling 22,700 shares during the quarter. Hennessy Advisors Inc.’s holdings in Fresenius Medical Care AG & Co. KGaA were worth $8,325,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Moran Wealth Management LLC lifted its holdings in Fresenius Medical Care AG & Co. KGaA by 67.4% in the 4th quarter. Moran Wealth Management LLC now owns 264,462 shares of the company’s stock worth $6,299,000 after purchasing an additional 106,438 shares during the last quarter. Diversified Management Inc. acquired a new stake in shares of Fresenius Medical Care AG & Co. KGaA in the fourth quarter worth $300,000. Assetmark Inc. increased its position in shares of Fresenius Medical Care AG & Co. KGaA by 44.8% during the fourth quarter. Assetmark Inc. now owns 45,522 shares of the company’s stock valued at $1,084,000 after purchasing an additional 14,078 shares during the period. Ritholtz Wealth Management grew its position in Fresenius Medical Care AG & Co. KGaA by 30.4% in the fourth quarter. Ritholtz Wealth Management now owns 24,006 shares of the company’s stock valued at $572,000 after acquiring an additional 5,595 shares during the period. Finally, DMC Group LLC grew its position in Fresenius Medical Care AG & Co. KGaA by 148.6% in the fourth quarter. DMC Group LLC now owns 19,474 shares of the company’s stock valued at $464,000 after acquiring an additional 11,642 shares during the period. 8.37% of the stock is currently owned by institutional investors and hedge funds.

Fresenius Medical Care AG & Co. KGaA Stock Performance

Fresenius Medical Care AG & Co. KGaA stock opened at $23.43 on Monday. The stock has a 50-day simple moving average of $23.13 and a 200 day simple moving average of $23.83. The company has a quick ratio of 0.92, a current ratio of 1.26 and a debt-to-equity ratio of 0.40. Fresenius Medical Care AG & Co. KGaA has a 12-month low of $20.94 and a 12-month high of $30.46. The stock has a market capitalization of $13.08 billion, a price-to-earnings ratio of 12.26, a P/E/G ratio of 2.21 and a beta of 0.89.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last released its quarterly earnings results on Saturday, February 14th. The company reported $1.69 earnings per share (EPS) for the quarter. Fresenius Medical Care AG & Co. KGaA had a return on equity of 8.73% and a net margin of 5.03%.The business had revenue of $5.95 billion during the quarter. On average, research analysts anticipate that Fresenius Medical Care AG & Co. KGaA will post 1.51 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have weighed in on FMS. Weiss Ratings cut Fresenius Medical Care AG & Co. KGaA from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, March 13th. The Goldman Sachs Group downgraded Fresenius Medical Care AG & Co. KGaA from a “buy” rating to a “neutral” rating in a research report on Tuesday, January 20th. Jefferies Financial Group cut Fresenius Medical Care AG & Co. KGaA from a “moderate sell” rating to a “strong sell” rating in a report on Tuesday, February 24th. Erste Group Bank lowered Fresenius Medical Care AG & Co. KGaA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, February 5th. Finally, Truist Financial set a $28.00 price target on Fresenius Medical Care AG & Co. KGaA in a report on Monday, January 5th. Five investment analysts have rated the stock with a Hold rating and four have given a Sell rating to the company’s stock. According to data from MarketBeat, Fresenius Medical Care AG & Co. KGaA presently has an average rating of “Reduce” and an average target price of $28.00.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.

In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.